OOIR: Observatory of International Research

Papers

(The H4-Index of European Heart Journal is 96. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)

Article	Citations
Meet the European Society of Cardiology Gold Medallists 2022	3063
Corrigendum to: Empagliflozin and serum potassium in heart failure: an analysis from EMPEROR-Pooled	2722
Correction to: The year in cardiovascular medicine 2022: the top 10 papers in heart failure and cardiomyopathies	2112
Weekly journal scan: a hard RAFTing to improve long-term survival in heart failure with severely reduced ejection fraction	1996
Unmeasured confounding is always unnerving: cannabis and cardiovascular risk	1694
Additional value of 18fluorodeoxyglucose positron emission tomography/computed tomography combined with intracardiac echocardiography to detect lead vegetations	1496
Obituary Joep Perk	1386
Taking inspiration from birds to improve flow in prosthetic heart valves: an European Research Council granted project	1382
Doubly committed ventricular septal defect closure using an eccentric occluder via minimal incision in the anterior median sternum through the left parasternal third intercostal space	1103
Elevated serum xylitol levels and cardiovascular risk: an active component or an innocent bystander?	1075
Isolated early peak cardiac troponin for clinical decision-making after elective cardiac surgery: useless at best	983
Pulmonary haemodynamics and pulmonary congestion: where are we now?	895
Female representation on editorial boards of the National Societies of Cardiology Journals of the European Society of Cardiology	831
A rare case of a dorsal mass caused by descending thoracic aortic dissection	788
New Guidelines and a focus on ischaemic heart disease, atrial fibrillation, innovative treatments of channelopathies	523
Residual leaks after transcatheter left atrial appendage closure: why and how to assess it?	510
Intricacies of aortic risk assessment studies: not a simple matter	463
Corrigendum to: Backup natural pacemaker found in the heart	462
Beyond modality: unaddressed variables and comorbidities in exercise interventions for coronary artery disease	409
Breakthrough outflow tract unlocking: modified transapical balloon-assisted transseptal mitral annuloplasty for high-risk mitral valve-in-ring patients	373
Arterial conduits for coronary bypass grafting: the set-point concept	342
Bulgarian Society of Cardiology: 50 years on	296
Weekly Journal Scan: no CLEAR evidence of cardiovascular benefits of colchicine after acute myocardial infarction	243
Early vascular disease of Olympian Paavo Nurmi despite a healthy lifestyle	239
From a club of friends to an institution: past successes and future challenges for the European Society of Cardiology	223

Synthetic assessment of cardiac autonomic modulation and Baevsky stress index in patients with synucleinopathies	220
Expression changes of circulating ACE2 regulating-microRNA profiles in patients with COVID-19 during hospitalisation	216
Patient characteristics and incidence of cardiac amyloidosis: an observational study in the UK clinical setting using electronic health records	215
Association of Body mass index and clinical outcomes in patient with coronary artery disease undergoing percutaneous coronary intervention	215
Interleukin-6 signalling, lipoprotein (a) lowering and cardiovascular disease: a mendelian randomisation study	200
Preserved left ventricular ejection fraction with abnormal myocardial work in sepsis	197
Heart failure with preserved ejection fraction: underdiagnosed and undertreated in patients with tricuspid regurgitation	196
Surgical myectomy for hypertrophic cardiomyopathy: procedural volume and outcomes	184
Comparison of rapid test for high-sensitivity troponin I with laboratory high-sensitivity troponin T in patients with acute chest pain - a prospective monocentric study	183
Beyond reproductive health: the cardiovascular risks of endometriosis	179
Impact of the atrial fibrillation better care pathway in clinically complex patients with atrial fibrillation: a report from the ESC-EHRA EORP-AF General Long-Term Registry	173
Risk of knowing too much: the tricky case of estimated glomerular filtration rate and treatment decisions in heart failure	169
Brugada syndrome: can polygenic risk scores help the clinician?	166
The extended role of 24 h ambulatory blood pressure monitoring for reflex syncope	166
Questionable metabolic flexibility during cardiac resynchronization therapy	164
Use of emgliflozine in cardiotoxicity treatment. EMPACARD-treatment registry. Six-months follow-up	163
Single-cell technologies to decipher cardiovascular diseases	162
Weekly Journal Scan: The promise of small interfering RNA in reducing lipoprotein(a)	160
Dementia in individuals with severe hypercholesterolemia: Korean nationwide cohort study	159
Novel DES cardiomyopathy presenting with lifelong syncope: diagnostic breakthrough via multimodal imaging and insertable cardiac monitor	159
Recent cardiac rehabilitation and its impact on cardiopulmonary exercise test variables in Brazilian cardiac transplant recipients	155
The COVID-19 pandemic and heart failure: lessons from GUIDE-HF	155
Differences in left atrial stain, endothelial glycocalyx, arterial elasticity and myocardial efficiency between ESUS, lacunar, cardioembolic and atherosclerotic type of stroke	154
Acute infections and inflammatory biomarkers in patients with acute pulmonary embolism	148
The gender difference in cause of death in Japanese atrial fibrillation patients: The Fushimi AF Registry	148
Multiparametric risk predictions for morbidity and mortality in patients with pulmonary arterial hypertension: insights from a nation-wide registry	144
Echocaridographic assessment of pulmonary hypertension: improving the probability	143
Cardiac troponin fragmentation in marathon runners. The MaraCat2 study	143
Twenty-year trends in peripheral artery disease, lower extremity revascularization, and lower extremity amputation in newly diagnosed type 2 diabetes	142
Evaluating the safety and long-term efficacy of triple vasodilator therapy for pulmonary arterial hypertension associated with congenital heart disease	140
Physiological disease pattern as assessed by PPGI in vessels with FFR and iFR discordance	139
Cumulative accelerometer-based light physical activity from childhood through young adulthood progressively decreases left ventricular mass in British youth: a 13-year longitudinal study	139
Novel cardiovascular magnetic resonance imaging heterogeneity biomarkers to diagnose and predict cardiovascular disease: a UK Biobank CMR strain study	137
Clinical outcomes of deferred lesions by IVUS versus FFR-guided treatment decision: the FLAVOUR trial substudy	137
Continuous monitoring of heart failure biomarker using a sensitive graphene-based electrical sensor	136
T regulatory cells lose their protective phenotype in patients with coronary artery disease (CAD)	135
Prevalence of diabetic nephropathy and subsequent cardiovascular outcomes: a nationwide study of 74,014 patients with type 2 diabetes	134
Real-time electrophysiological characterization of acute and chronic radiofrequency ablation lesions	133
Association between the changes in walking speed during 6 months after discharge and subsequent prognosis in older patients with heart failure: report from a multicenter prospective cohort study	132
Left main coronary artery dimension and variation in Thai population	131
Validation of HAS-BELD scoring system and risk factors of bleeding with warfarin among non-valvular atrial fibrillation patients	130
Deep learning for fully automated echocardiographic measurements of left ventricular wall thickness and chamber dimensions in the parasternal long-axis view	128
New definition of hypotension in patients with reflex syncope using 24-hour ambulatory blood pressure monitoring (SynABPM Study)	128
Spontaneous, independent, single-center renal denervation registry of a resistant hypertension multidisciplinary team	128
Management of hospital resources for patients with myocardial infarction with non-obstructive coronary arteries (MINOCA) - an approach to deescalate ?	127
The expression of selected microRNAs enables identification of patients with functional atrial tricuspid regurgitation. New insights into TR pathophysiology	126
Epicardial adipose tissue volume and density is associated with cardiac dysfunction in asymptomatic people with type 2 diabetes	126
Early diastolic strain rate and its associations with estimated glomerular filtration rate and albuminuria	124
Post-systolic shortening index by echocardiography evaluation of dyssynchrony in the non-dilated and hypertrophied left ventricle	122
Atherogenic lipoprotein profile associated with anthropometric indices of obesity and their association with cardiometabolic risk markers: a cross-sectional study in community	122

Right ventricular free wall longitudinal strain (RVFWSL) a new outcome predictor in patients candiate for TAVI	118
Survival penalty in patients undergoing transcatheter versus surgical aortic valve replacement: is it just a question of frailty? Insights from a large cohort with demographic matching	116
Permanent pacemaker implantation is associated with an increased risk of heart failure hospitalization in transcatheter aortic valve implantation patients with reduced systolic function	114
Implementing dynamic atrioventricular delay optimization for cardiac resynchronization therapy: an economic analysis in the EU5 countries	113
Practicing what you preach. Do cardiology trainees in the United Kingdom follow the lifestyle advice that they would give to patients?	111
What is there to EAARN with a CRT implantation? Predictive factors of mortality or clinical deterioration in patients receiving cardiac resynchronization therapy based on pre-implant factors	110
Improving early mortality risk detection in light-chain cardiac amyloidosis patients with routine echocardiographic indicators and mayo staging	109
Extraction of leadless and tranvenous pacemakers: occurrence, causes and complications from a national US database	108
Factors for incorrect automated atrial fibrillation identification in large-scale screening	106
Dietary sodium intake and outcomes: a secondary analysis from SODIUM - HF	104
Duration of sinus rhythm after direct current cardioversion does not predict recurrence of atrial fibrillation after subsequent catheter ablation: a multicentre study	104
Does the quality index of adherence to the evidence-based guidelines predict mortality in patients with myocardial infarction?	104
iRight4Me: individualisation of P2Y12 inihibitors in the realworld practice - an interim report	103
Basal natriuresis as a predictor of diuretic resistance and clinical evolution in acute heart failure	103
Quantitative assessment of myocardial fibrosis by digital image analysis: an adjunctive tool for pathologist ground truth	102
Atrial fibrillation organisation correlates with ventricular response regularity in patients with persistent atrial fibrillation	102
Optimal CW-Doppler derived parameter for the diagnosis of iatrogenic mitral stenosis during transcatheter edge-to-edge repair for mitral regurgitation	102
Impact of aortic valve calcium score on conductive disturbances after transcatheter aortic valve implantation: a monocentre retrospective study	101
Impact of the thin-walled sheath on the distal radial artery occlusion: a randomized trial	100
Incidentally induced atrial fibrillation during programmed electrical stimulation in patients with depressed left ventricular systolic function after an acute myocardial infarction: a CARISMA substudy	99
Prognostic role of data transmitted by implanted cardiac electric devices in patients with advanced heart failure referred for heart transplantation	99
Comparative study of the effects of left ventricular and biventricular pacing on indices of cardiac function and clinical status of heart failure patients: preliminary results of READAPT study	96